Measured Wealth Private Client Group’s Thermo Fisher Scientific TMO Stock Holding History

Measured Wealth Private Client Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-36	Closed	-$17.7K	–	762
2026 Q1	$17.7K	Hold	36	–	–	﹤0.01%	503
2025 Q4	$20.9K	Sell	36 -134	-79%	-$75.8K	0.01%	471
2025 Q3	$82.5K	Buy	+170	New	+$79.1K	0.02%	254
2019 Q3	–	Sell	-1,035	Closed	-$304K	–	199
2019 Q2	$304K	Buy	+1,035	New	+$285K	0.18%	125
2018 Q4	–	Sell	-383	Closed	-$93K	–	650
2018 Q3	$93K	Buy	+383	New	+$88.1K	0.06%	248

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Measured Wealth Private Client Group's TMO Position: Q2 2026 in Review

Measured Wealth Private Client Group sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 36 shares — an estimated $17.7K sold.

Measured Wealth Private Client Group first reported a position in TMO in Q3 2018 and held it in 5 quarters. The position peaked at $304K in Q2 2019. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Measured Wealth Private Client Group reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Measured Wealth Private Client Group sold 36 Thermo Fisher Scientific shares in Q2 2026, an estimated $17.7K.
Measured Wealth Private Client Group first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 5 quarters.
Measured Wealth Private Client Group's Thermo Fisher Scientific position peaked at $304K in Q2 2019.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.